Competition record
Medtronic
Deep profile · 1 linked library matter
Medtronic is a large medical-device company. Plasmatica sued it in September 2026 over anti-fog products and portfolio pricing. The case is newly filed.
Overview
Medtronic sells devices and related products to hospitals worldwide. Installed equipment and group contracts are how hospitals buy, often across a whole portfolio rather than one SKU.
On September 18, 2026 Plasmatica sued, alleging share commitments of 80 to 90 percent and penalty pricing when a hospital trialed a rival anti-fog product. A complaint is not a finding.
Hospital contracting of this kind is common. It becomes an antitrust allegation when the discount is said to block a rival from even getting a trial.
Competition footprint
Portfolio pricing can be a discount or, on the plaintiff's account, a penalty for dealing with a rival.
The relevant buyers are hospital supply committees, not patients at a pharmacy counter.
No ruling on the complaint is recorded in this library.
Consumer & business angle
Hospitals pay the contract. Patients receive the device and rarely see the bundle.
A small device maker needs a trial in the operating room before it can win a contract.
What to watch
- Any motion to dismiss the Plasmatica complaint.
- How the court treats share commitments in hospital contracts.
Markets
medical devices · surgical products · laparoscopic anti-fog devices
Also known as: medtronic